Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Diabetes and COVID-19—Growing Understanding of the Links

Characteristics and Diabetes Control in Adults With Type 1 Diabetes Admitted With COVID-19 Infection

  1. Maria Vamvini1,2,
  2. Vasileios-Arsenios Lioutas3 and
  3. Roeland J.W. Middelbeek1,2⇑
  1. 1Joslin Diabetes Center, Harvard Medical School, Boston, MA
  2. 2Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
  3. 3Division of Cerebrovascular Diseases, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
  1. Corresponding author: Roeland J.W. Middelbeek, roeland.middelbeek{at}joslin.harvard.edu
Diabetes Care 2020 Oct; 43(10): e120-e122. https://doi.org/10.2337/dc20-1540
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Diabetes has been identified as one of the major risk factors for developing severe forms of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1). While data show a higher incidence of severe acute respiratory distress syndrome and increased mortality in patients with diabetes, the majority of these patients have type 2 diabetes (2), and less is known about the implications of type 1 diabetes in COVID-19. A report from the U.K. describes the COVID-19 mortality rate as significantly higher in older patients with type 1 diabetes compared with those with type 2 diabetes (3). Among young adults with type 1 diabetes in the U.S., diabetic ketoacidosis (DKA) was commonly encountered in those diagnosed with COVID-19 (4). Little is known about adults with type 1 diabetes and COVID-19 who require hospitalization. The goal of this study was to define the clinical characteristics, outpatient diabetes management and control, and disease course of people with type 1 diabetes who were admitted to a tertiary care center for COVID-19.

We retrospectively reviewed the charts and collected data for all patients with an established diagnosis of type 1 diabetes who were admitted to Beth Israel Deaconess Medical Center in Boston, MA, between 1 March 2020 and 1 June 2020. After excluding patients admitted for obstetrical reasons, we identified 35 adults with confirmed type 1 diabetes. Preceding data up to 6 months on glycemic control, diabetes management, and complications as well as the in-hospital course were recorded. We calculated insulin dose per kilogram of body weight. We defined a composite primary outcome including intensive care unit (ICU) admission, intubation, or death. The study was approved as exempt by the local institutional review board. Statistical analyses were performed by using unpaired two-sided t test for normally distributed continuous variables, Wilcoxon rank-sum test for nonnormally distributed continuous variables, and χ2 for categorical variables. We set the level of statistical significance at a P value <0.05.

We describe a series of hospitalized patients with type 1 diabetes and COVID-19 and compare this series with patients with type 1 diabetes who did not have COVID-19 and were simultaneously admitted to the hospital (Table 1). Seven patients were positive for COVID-19 by PCR test. The remainder were negative for COVID-19 (n = 24) or not tested (n = 4) and were used as the control group in this analysis. COVID-19+ patients were of similar age as COVID-19− adults with type 1 diabetes. There was a larger percentage of non-Hispanic Black Americans in the COVID+ group as compared with the COVID-19− group. We observed no significant differences in sex, body weight, glucose, or HbA1c on admission between groups. The outpatient insulin regimen for all COVID-19+ adults with type 1 diabetes consisted of multiple daily injections. Outpatient insulin doses corrected for body weight and glycemic control in the months preceding admission were not different between groups. DKA occurred in one patient in the COVID+ group and two in the COVID-19− group. Both COVID-19+ and COVID-19− patients with type 1 diabetes had a significant number of preexisting, diabetes-related complications. More than 50% of patients in each group had been diagnosed with nephropathy, and 14% in each group were organ transplant recipients on immunosuppression therapy. The composite outcome occurred in two COVID-19+ patients (ICU admission without intubation, both recovered) and in four COVID-19− patients, including two deaths.

View this table:
  • View inline
  • View popup
Table 1

Characteristics of adults with type 1 diabetes with and without COVID-19 infection admitted to a tertiary center between 1 March 2020 and 1 June 2020

Our data show remarkable similarities in age, glycemic control, and diabetes management between COVID-19+ patients and patients admitted for other reasons. A larger percentage of COVID-19+ patients were non-Hispanic Black, which is in line with prior data from larger retrospective studies that have shown that COVID-19 has disproportionately affected this population (5). Our data show a lower incidence of DKA compared with that reported by Ebekozian et al. (4). In the latter study, conducted by questionnaire, only 57% of the COVID-19–confirmed patients required hospital admission, and this group included five cases (15%) of new-onset type 1 diabetes. The difference in DKA incidence could be related to differences in age, as patients in our study were significantly older. New-onset type 1 diabetes, which carries a high risk of DKA, was not seen in our cohort.

Taken together, these data demonstrate that adult patients with type 1 diabetes who were admitted as COVID-19+ show similar outpatient glycemic control prior to admission and similar clinical characteristics upon admission as COVID-19− patients with type 1 diabetes. Larger studies are needed to confirm these findings in younger adults and children and to better characterize risk factors for hospital admission in people with type 1 diabetes and COVID-19.

Article Information

Funding. M.V. was supported by National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grants T32-DK007260 and F32-DK126432. R.J.W.M. was supported by NIH NIDDK grant K23-DK114550.

Duality of Interest. V.L. reports consulting fees from Qmetis unrelated to this work. No other potential conflicts of interest relevant to this article were reported.

Author Contributions. All authors were involved in writing, study design, review, editing, and final approval. R.J.W.M. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Footnotes

  • This article is part of a special article collection available at https://care.diabetesjournals.org/collection/diabetes-and-COVID19.

  • Received June 22, 2020.
  • Accepted July 1, 2020.
  • © 2020 by the American Diabetes Association
https://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.

References

  1. ↵
    1. Zhu L,
    2. She Z-G,
    3. Cheng X, et al
    . Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab 2020;31:1068–1077.e3
    OpenUrlCrossRefPubMed
  2. ↵
    1. Cariou B,
    2. Hadjadj S,
    3. Wargny M, et al.; CORONADO investigators
    . Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia 2020;63:1500–1515
    OpenUrl
  3. ↵
    1. Barron E,
    2. Bakhai C,
    3. Kar P, et al
    . Type 1 and type 2 diabetes and COVID-19 related mortality in England: a whole population study. 17 May 2020 [preprint]. SSRN:http://dx.doi.org/10.2139/ssrn.3605225
  4. ↵
    1. Ebekozien OA,
    2. Noor N,
    3. Gallagher MP,
    4. Alonso GT
    . Type 1 diabetes and COVID-19: preliminary findings from a multicenter surveillance study in the U.S. Diabetes Care 2020;43:e83–e85
    OpenUrlFREE Full Text
  5. ↵
    1. Suleyman G,
    2. Fadel RA,
    3. Malette KM, et al
    . Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit. JAMA Netw Open 2020;3:e2012270
    OpenUrl
PreviousNext
Back to top
Diabetes Care: 43 (10)

In this Issue

October 2020, 43(10)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Characteristics and Diabetes Control in Adults With Type 1 Diabetes Admitted With COVID-19 Infection
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Characteristics and Diabetes Control in Adults With Type 1 Diabetes Admitted With COVID-19 Infection
Maria Vamvini, Vasileios-Arsenios Lioutas, Roeland J.W. Middelbeek
Diabetes Care Oct 2020, 43 (10) e120-e122; DOI: 10.2337/dc20-1540

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Characteristics and Diabetes Control in Adults With Type 1 Diabetes Admitted With COVID-19 Infection
Maria Vamvini, Vasileios-Arsenios Lioutas, Roeland J.W. Middelbeek
Diabetes Care Oct 2020, 43 (10) e120-e122; DOI: 10.2337/dc20-1540
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Diabetes and COVID-19: Moving From News to Knowledge and a Glucose Hypothesis
  • No Evidence of Increased Hospitalization Rate for COVID-19 in Community-Dwelling Patients With Type 1 Diabetes
  • Increased Hepatic ACE2 Expression in NAFL and Diabetes—A Risk for COVID-19 Patients?
Show more Diabetes and COVID-19—Growing Understanding of the Links

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.